Substratos Cromogénicos

Os substratos cromogênicos são compostos que produzem uma mudança de cor visível quando são metabolizados por enzimas específicas. Esses substratos são amplamente utilizados em ensaios diagnósticos, pesquisa bioquímica e ensaios imunoenzimáticos (ELISA) para detectar e quantificar a atividade enzimática. A mudança de cor permite uma identificação visual fácil e rápida das reações enzimáticas, tornando os substratos cromogênicos ferramentas essenciais na análise laboratorial. Na CymitQuimica, oferecemos uma seleção diversificada de substratos cromogênicos de alta qualidade para apoiar suas aplicações de pesquisa e diagnóstico.

Ler mais

20
- 50
- 100
- 200

produtos por página. 790 produtos desta categoria.

Dados do produto	Pureza	Gama de preços	Estimativa de entrega
5-Bromo-4-chloro-3-indoxyl-β-D-glucopyranoside REF: 3D-B-7250CAS: 15548-60-4	Min. 98.0 Area-%	A consultar	Qua 12 Mar 25
Aldol® 458 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4691_P00CAS: 1254797-77-7	Min. 95.0 Area-%	A consultar	Qua 12 Mar 25
Aldol® 495 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4701_P00CAS: 1254798-26-9	Min. 95.0 Area-%	640,00 €~2.296,00 €	Qua 12 Mar 25
6-Bromo-2-naphthyl-α-D-galactopyranoside REF: 3D-B-8925CAS: 25997-59-5	Min. 98 Area-%	A consultar	Qua 12 Mar 25
5-Bromo-4-chloro-3-indoxyl-α-D-fucopyranoside REF: 3D-B-7134CAS: 1301706-80-8	- - -	A consultar	Qua 12 Mar 25
Aldol® 515 acetate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4673_P00CAS: 2484872-46-8	Min. 95.0 Area-%	A consultar	Qua 12 Mar 25
Aldol® 495 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4715_P00CAS: 2484873-16-5	Of Solute (Hplc) 95.0 To 100.0 Area-%	A consultar	Qua 12 Mar 25
Aldol® 470 choline phosphate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4672_P00CAS: 1254798-15-6	Min. 95 Area-%	A consultar	Qua 12 Mar 25
5-Bromo-4-chloro-3-indoxyl-α-L-arabinofuranoside REF: 3D-B-7044	Min. 99.0 Area-%	A consultar	Qua 12 Mar 25
Aldol® 458 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4714_P00CAS: 2484873-15-4	Of Solute (Hplc) 98.0 To 100.0 Area-%	A consultar	Qua 12 Mar 25
5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt anhydrous REF: 3D-B-7398CAS: 129541-41-9	Min. 98.0 Area-%	A consultar	Qua 12 Mar 25
Aldol® 470 butyrate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4682_P00CAS: 2484872-49-1	Min. 95.0 Area-%	A consultar	Qua 12 Mar 25
6-Bromo-2-naphthyl-2-acetamido-2-deoxy-β-D-glucopyranoside REF: 3D-B-8932CAS: 212069-27-7	- - -	A consultar	Qua 12 Mar 25
Aldol® 518 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4675_P00CAS: 2484872-47-9	Min. 95 Area-%	A consultar	Qua 12 Mar 25
5-Bromo-4-chloro-3-indoxyl butyrate REF: 3D-B-7050CAS: 129541-43-1	Min. 98.0 Area-%	A consultar	Qua 12 Mar 25
Aldol® 455 α-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4688_P00	Min. 95.0 Area-%	671,00 €~2.657,00 €	Qua 12 Mar 25
5-Bromo-4-chloro-3-indoxyl myristate REF: 3D-B-7408CAS: 341972-95-0	Min. 98 Area-%	A consultar	Qua 12 Mar 25
Aldol® 484 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4698_P00CAS: 2484872-58-2	Min. 95.0 Area-%	A consultar	Qua 12 Mar 25
Aldol® 470 phosphate, disodium salt, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4678_P00CAS: 2484872-48-0	Min. 95.0 Area-%	A consultar	Qua 12 Mar 25
5-Bromo-4-chloro-3-indoxyl oleate REF: 3D-B-7412CAS: 341972-97-2	Min. 98 Area-%	A consultar	Qua 12 Mar 25

5g		729,00 €
10g		1.188,00 €
25g		2.698,00 €
50g		4.901,00 €
100g		8.900,00 €

1g		A consultar
5g		A consultar
250mg		A consultar
500mg		A consultar
2500mg		A consultar

25mg		A consultar
100mg		A consultar

Substratos Cromogénicos

5-Bromo-4-chloro-3-indoxyl-β-D-glucopyranoside

Ref: 3D-B-7250

Aldol® 458 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4691_P00

Aldol® 495 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4701_P00

6-Bromo-2-naphthyl-α-D-galactopyranoside

Ref: 3D-B-8925

5-Bromo-4-chloro-3-indoxyl-α-D-fucopyranoside

Ref: 3D-B-7134

Aldol® 515 acetate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4673_P00

Aldol® 495 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4715_P00

Aldol® 470 choline phosphate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4672_P00

5-Bromo-4-chloro-3-indoxyl-α-L-arabinofuranoside

Ref: 3D-B-7044

Aldol® 458 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4714_P00

5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt anhydrous

Ref: 3D-B-7398

Aldol® 470 butyrate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4682_P00

6-Bromo-2-naphthyl-2-acetamido-2-deoxy-β-D-glucopyranoside

Ref: 3D-B-8932

Aldol® 518 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4675_P00

5-Bromo-4-chloro-3-indoxyl butyrate

Ref: 3D-B-7050

Aldol® 455 α-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4688_P00

5-Bromo-4-chloro-3-indoxyl myristate

Ref: 3D-B-7408

Aldol® 484 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4698_P00

Aldol® 470 phosphate, disodium salt, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4678_P00

5-Bromo-4-chloro-3-indoxyl oleate

Ref: 3D-B-7412